Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01
•Optimal sequencing of radiotherapy and chemotherapy is not well defined for stage III NSCLC.•Cisplatin-based chemotherapy as induction or consolidation of chemoradiotherapy is safe.•Response rates were similar in both arms without difference in survival.